INTERNATIONAL PATENT: ABLYNX NV, SANOFI FILES APPLICATION FOR "HER2 BINDING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS, CONSTRUCTS COMPRISING THE SAME AND USES THEREOF"

GENEVA, March 17 -- ABLYNX NV (Technologiepark 219052 Zwijnaarde), SANOFI (46 avenue de la Grande Armee75017 Paris) filed a patent application (PCT/EP2025/075276) for "HER2 BINDING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS, CONSTRUCTS COMPRISING THE SAME AND USES THEREOF" on Sep 05, 2025. With publication no. WO/2026/052756, the details related to the patent application was published on Mar 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BRUCH, Eduardo (c/o Sanofi, Patent Department, 450 WaterStreetCambridge, MA, 02141), CALLAHAN, Michelle (c/o Sanofi, Patent Department, 450 WaterStreetCamb...